• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Personal knowledge on novel coronavirus pneumonia.

作者信息

Kang Han-Yu-Jie, Wang Yi-Shan, Tong Zhao-Hui

机构信息

Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.

出版信息

Chin Med J (Engl). 2020 May 5;133(9):1121-1122. doi: 10.1097/CM9.0000000000000757.

DOI:10.1097/CM9.0000000000000757
PMID:32068600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7213614/
Abstract
摘要

相似文献

1
Personal knowledge on novel coronavirus pneumonia.关于新型冠状病毒肺炎的个人认识。
Chin Med J (Engl). 2020 May 5;133(9):1121-1122. doi: 10.1097/CM9.0000000000000757.
2
Extracorporeal Membrane Oxygenation for COVID-19.用于治疗新型冠状病毒肺炎的体外膜肺氧合
Innovations (Phila). 2020 Jul/Aug;15(4):306-313. doi: 10.1177/1556984520937821. Epub 2020 Jul 21.
3
Extracorporeal membrane oxygenation support in 2019 novel coronavirus disease: indications, timing, and implementation.2019年新型冠状病毒病的体外膜肺氧合支持：适应证、时机及实施
Chin Med J (Engl). 2020 May 5;133(9):1115-1117. doi: 10.1097/CM9.0000000000000778.
4
[Intervention timing of invasive mechanical ventilation and extracorporeal membrane oxygenation in the treatment of severe COVID-19].[有创机械通气和体外膜肺氧合在重症新型冠状病毒肺炎治疗中的干预时机]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Sep 12;43(9):725-728. doi: 10.3760/cma.j.cn112147-20200628-00754.
5
Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how?为新型冠状病毒肺炎患者提供体外膜肺氧合治疗：是什么、谁来做、何时做以及如何做？
Anaesthesia. 2020 Aug;75(8):997-1001. doi: 10.1111/anae.15099. Epub 2020 May 2.
6
Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation.为新冠肺炎重症患者做准备：体外膜肺氧合的潜在作用
JAMA. 2020 Apr 7;323(13):1245-1246. doi: 10.1001/jama.2020.2342.
7
Implementation of veno-venous extracorporeal membrane oxygenation in a COVID-19 convalescent.在一名新冠康复者中实施静脉-静脉体外膜肺氧合。
Anaesthesiol Intensive Ther. 2020;52(3):253-255. doi: 10.5114/ait.2020.97956.
8
Extracorporeal membrane oxygenation in COVID-19.COVID-19中的体外膜肺氧合
Cardiol J. 2020;27(2):216-217. doi: 10.5603/CJ.a2020.0053. Epub 2020 Apr 14.
9
Optimal therapeutic strategy using extracorporeal membrane oxygenation in patients with COVID-19.新型冠状病毒肺炎患者使用体外膜肺氧合的最佳治疗策略
J Card Surg. 2020 Oct;35(10):2872-2873. doi: 10.1111/jocs.14831.
10
Surge capacity and updated admission criteria: response of the NHS-commissioned national respiratory extracorporeal membrane oxygenation network to the COVID-19 pandemic.应急能力与更新后的入院标准：英国国家医疗服务体系（NHS）委托的全国呼吸体外膜肺氧合网络对新冠疫情的应对措施
Br J Anaesth. 2020 Sep;125(3):e282-e283. doi: 10.1016/j.bja.2020.06.008. Epub 2020 Jun 10.

引用本文的文献

1
COVID-19 Patients: A Systematic Review and Meta-Analysis of Laboratory Findings, Comorbidities, and Clinical Outcomes Comparing Medical Staff versus the General Population.新冠病毒疾病患者：一项关于实验室检查结果、合并症以及比较医务人员与普通人群临床结局的系统评价和荟萃分析。
Osong Public Health Res Perspect. 2020 Oct;11(5):269-279. doi: 10.24171/j.phrp.2020.11.5.02.

本文引用的文献

1
Protocol for Prevention and Control of COVID-19 (Edition 6).新型冠状病毒肺炎防控方案（第六版）
China CDC Wkly. 2020 May 8;2(19):321-326. doi: 10.46234/ccdcw2020.082.
2
[Recommendations on extracorporeal life support for critically ill patients with novel coronavirus pneumonia].[新型冠状病毒肺炎危重症患者体外生命支持治疗的推荐意见]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 9;43(0):E009. doi: 10.3760/cma.j.issn.1001-0939.2020.0009.
3
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome.糖皮质激素治疗中东呼吸综合征危重症患者。
Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767. doi: 10.1164/rccm.201706-1172OC.
4
Corticosteroids as adjunctive therapy in the treatment of influenza.皮质类固醇作为流感治疗的辅助疗法。
Cochrane Database Syst Rev. 2016 Mar 7;3:CD010406. doi: 10.1002/14651858.CD010406.pub2.
5
Efficacy and Safety of Corticosteroids for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis.糖皮质激素治疗社区获得性肺炎的疗效和安全性：系统评价和荟萃分析。
Chest. 2016 Jan;149(1):209-19. doi: 10.1378/chest.15-1733. Epub 2016 Jan 6.
6
Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment.肺孢子菌不断演变的健康影响：诊断与治疗的百年进展
JAMA. 2009 Jun 24;301(24):2578-85. doi: 10.1001/jama.2009.880.
7
SARS: systematic review of treatment effects.严重急性呼吸综合征：治疗效果的系统评价
PLoS Med. 2006 Sep;3(9):e343. doi: 10.1371/journal.pmed.0030343.
8
Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.皮质类固醇对持续性急性呼吸窘迫综合征的疗效与安全性
N Engl J Med. 2006 Apr 20;354(16):1671-84. doi: 10.1056/NEJMoa051693.